At the conclusion of this session, participants will be able to:
- construct an approach to diagnosing and managing challenging infectious disease syndromes occurring in organ and stem cell transplant recipients
E. Blumberg, Merck: Grant Investigator and Scientific Advisor , multicenter trial and I am site PI; no financial support for scientific advisory committee and Research support . Bristol Myers Squibb: DSMB member , payment for DSMB work . Glaxo: member of DSMB and Scientific Advisor , no financial support . Shire: Grant Investigator , site PI for multicenter trial .
L. Danziger-Isakov, Merck: Consultant and Research Contractor , Consulting fee and Research support . Ansun BioPharma: Research Contractor , Research support . Roche: Research Contractor , Research support . Chimerix: Research Contractor , Research support . Astellas: Research Contractor , Research support .
C. Cervera, Qiagen: Speaker's Bureau , Speaker honorarium . Merck: Scientific Advisor , Consulting fee .
A. P. Limaye, Merk: Consultant and Investigator , Consulting fee and Research grant . Astellas Pharma Inc.: Consultant and Investigator , Consulting fee . Helocyte Inc.: Consultant , Consulting fee .